Profile
Sophia Park currently works at MyoKardia, Inc., as Vice President from 2020, Mirati Therapeutics, Inc., as Vice President from 2024, Rayzebio, Inc., as Vice President from 2024, and Karuna Therapeutics, Inc., as Vice President from 2024.
Sophia Park active positions
| Companies | Position | Start |
|---|---|---|
| MYOKARDIA, INC. | Corporate Officer/Principal | 17/11/2020 |
| MIRATI THERAPEUTICS | Corporate Officer/Principal | 23/01/2024 |
| RAYZEBIO, INC. | Corporate Officer/Principal | 26/02/2024 |
| KARA THER | Corporate Officer/Principal | 18/03/2024 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
MyoKardia, Inc.
MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Karuna Therapeutics, Inc.
Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines for psychiatric and neurological disorders like schizophrenia and Alzheimer’s disease | Health Technology |
Rayzebio, Inc.
Rayzebio, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapeutics for cancer treatment | Health Technology |
- Stock Market
- Insiders
- Sophia Park
















